A DNA nano-harvester stays on its track inside tumor cells, measuring cancer aggressiveness by detecting a key microRNA biomarker.

MicroRNAs, whose discovery was recognized with the 2025 Nobel Prize in Physiology or Medicine, are central regulators of gene expression, yet a fundamental question has remained unanswered: how cells ...

In a recent study published in the journal npj Aging, researchers developed a urinary microRNA (miRNA) aging clock that predicts chronological age from urinary miRNA profiles, with deviations used as ...

Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish between harmless and aggressive forms of the disease. This review highlights how ...

In this interview, industry expert Dr. Lohit Khera discusses the evolving role of microRNA in research, diagnostics, and precision medicine. He also highlights the latest RNA extraction and analysis ...

Canadian biotech startup Afynia Laboratories, a spin-out from McMaster University in Ontario, has picked up $5 million in seed funding to commercialize a blood test for endometriosis — a medical ...

AIA is transforming how the architecture profession and the AEC industry design for climate, people, and communities. Our members are leading the way, acting as a force multiplier for sustainable, ...

Victor Ambros receives funding from the U.S. National Institutes of Health. The Conversation Weekly podcast caught up with Victor Ambros from his lab at the UMass Chan Medical School to learn more ...

Two Massachusetts scientists have been recognized with the Nobel Prize in Physiology or Medicine for their role in the discovery of microRNA — key to the understanding of gene regulation and potential ...

The Nobel Prize in physiology or medicine was awarded Monday to Americans Victor Ambros and Gary Ruvkun for their discovery of microRNA, tiny pieces of genetic material that alter how genes work at ...